Drug-tolerant but initially EGFRT790M-negative tumor cells that undergo genetic evolution to acquire resistance to EGFR inhibitors are more resistant than pre-existing EGFRT790M -positive clones to subsequent therapy.
- Aaron N Hata
- Matthew J Niederst
- Jeffrey A Engelman